Revealis Joins Cancer Vaccine Race: The Innovative TEIPP Strategy Explained
Revealis Biotherapeutics has launched in the Netherlands to develop TEIPP cancer vaccines, tackling a mechanism of resistance where tumors disrupt their antigen-processing machinery to hide from T cells, according to European Biotechnology and biotechnews.nl. How TEIPP Vaccines Target Invisible Cancer Cells Tumors frequently evade T cells by shutting down the machinery that displays warning signs … Read more